Results 231 to 240 of about 971,148 (308)

Ezetimibe vs Inclisiran in Coronary Artery Disease and Hyperlipidemia: A Propensity-Matched Analysis. [PDF]

JACC Adv
Akbar UA, Ijaz H, Banga A, Cheshire M, Shakeel S, Jena N, Alexander T, Dani SS.   +7 more
europepmc   +1 more source

Concomitant Transcatheter Edge‐to‐Edge Repair for Mitral and Tricuspid Regurgitation for Polyvalvular Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Omar Khan, Matthew Summers
wiley   +1 more source

Around and Through: Successful Mitral Paravalvular Leakage Closure Using Both Anterograde and Retrograde Approaches

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa, Luca Nai Fovino, Tommaso Fabris, Giuseppe Tarantini   +3 more
wiley   +1 more source

Deep learning image reconstruction optimizes coronary artery calcium quantification. [PDF]

Front Cardiovasc Med
Zhou T, Liu M, Wu T, Zhang M, Dong J, Ma Z, Li Y, Ba X.   +7 more
europepmc   +1 more source

Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid, Arindam Bagga, Kevin Kennedy, John T. Saxon, Chetan P. Huded   +4 more
wiley   +1 more source

RNA-Based Therapies for Hypercholesterolemia and Coronary Artery Disease. [PDF]

Cureus
Lopez Mendoza MJ, Contreras Figueroa N, Valle Mena MJ, Ulloa A, Jiron Vindas J, Salazar Estrada MA.   +5 more
europepmc   +1 more source

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu, Antonin Trimaille, Amandine Granier, Adrien Carmona, Anis Elidrissi, Marion Kibler, Laurence Jesel, Patrick Ohlmann, Laurent Sattler, Olivier Morel   +9 more
wiley   +1 more source

Rare Intraoperative Left Coronary Artery Dissection in Acute Type A Aortic Dissection: VA-ECMO-Assisted Coronary Artery Bypass Grafting. [PDF]

Clin Case Rep
Nakamura Y, Saku K, Homma S, Moriyama N, Ota T.   +4 more
europepmc   +1 more source